clinical trial · NCT04176133
Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
Robert J. Pignolo·phase2·completed·n = 61
HealthyEntolimodPlaceboInfluenza vaccine
brief summary
Researchers are evaluating the safety and effectiveness of a single administration of entolimod when administered at the same time as the influenza vaccine (flu vaccine).
started
Oct 30, 2019
primary completion
Mar 30, 2022
completion
Mar 30, 2022
last updated
Jun 22, 2023
official title
A Randomized, Double-Blind, Placebo-Controlled, Single-Administration, Dose-Escalation Study of Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol